Doxylamine Succinate And Pyridoxine Hydrochloride
Product Images NDC 0378-4615

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 0378-4615). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochlorothiazide Delayed-release Tablets 10 mg/10 mg Bottle Label (Image 01)

Label for Doxylamine Succinate and Pyridoxine Hydrochloride 10 mg/10 mg delayed-release tablets by Mylan Pharmaceuticals Inc. The label indicates the product contains 100 tablets with a warning to swallow whole. It includes dosage and storage instructions, manufacturer information, barcodes, and safety warnings to keep out of reach of children.*

FDA Label Image

Doxylamine Succinate Structural Formula (Image 02)

Chemical structure diagram showing the molecular structures of Doxylamine Succinate and Pyridoxine Hydrochloride. The image depicts the two distinct chemical entities represented by their atomic and bond arrangements.*

FDA Label Image

Pyridoxine Hydrochloride Structural Formula (Image 03)

Chemical structure of pyridoxine hydrochloride, one of the active ingredients in Doxylamine Succinate and Pyridoxine Hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.